Linical Accelovance Leadership
Linical Accelovance's commitment to providing quality services starts with our people. Our team members are passionate about their work and are dedicated to fulfilling each client's requirements in a timely, accurate, well managed and cost-effective manner.
Our executive management team combines entrepreneurial business talents, clinical and medical expertise, and biotech industry experience to effectively lead the vision of the company. The following individuals are the foundation of Accelovance's ability to the address clinical needs and business objectives of those we serve.
Vita Lanoce, MS, Chief Executive Officer
Ms. Lanoce leads the Linical Accelovance organization. Ms. Lanoce ensures operational excellence is achieved by applying high industry standards, policies, systems and processes across the organization. In addition to leading the organization, Ms. Lanoce oversees the organization’s Clinical Operations and Biometrics division, including Data Management and Biostatistics. Ms. Lanoce has more than 22 years of experience in the clinical research industry. Prior to joining Accelovance, Ms. Lanoce had a 15 year tenure with Radiant Development where she held positions of increasing responsibility including Site Director, Director Regional Operations, Director Operations, and Vice President Clinical Operations. Prior to joining Radiant Development, Ms. Lanoce was the Managing Partner and Director of Clinical Operations for two clinical research facilities located in Stuart and Lake Worth, Florida. Ms. Lanoce has held a variety of positions in the biopharmaceutical industry including Clinical Scientist at Bristol-Meyers Squibb and Regional Manager for Covance. Ms. Lanoce holds a Master's of Science in Biomedical Engineering from Rutgers University and a Bachelor of Arts in Biology from Manhattanville College.
Tracy Goeken, MD, Chief Medical Officer
As Chief Medical Officer of Linical Accelovance, Dr. Goeken is responsible for providing strategic and operational leadership regarding the Company’s Global Medical and Scientific Operations. Dr. Goeken oversees clinical development functions and activities within the company including Medical, Regulatory, Medical Writing and Pre and Post Market Pharmacovigilance departments ensuring global alignment and operational excellence. Dr. Goeken received his M.D. from St. Christopher’s College of Medicine in the UK, having completed his clinical training at LSU Health Sciences Center in Louisiana and Sub-Internship in High Risk Maternal Fetal Medicine at Ochsner Clinic Foundation in Louisiana. Prior to joining Linical Accelovance, Dr. Goeken held positions at The Methodist Hospital Research Institute in Houston, Texas, Pharm-Olam International, Nuron Biotech and Somahlution. Dr. Goeken has substantial global experience with clinical development and medical affairs functions leading global product development efforts from first in man/proof of concept through pivotal study, product launch and beyond. He is experienced with multiple therapeutic indications across drug/biologic and medical device platforms.
Mary Lyda, Chief Corporate Compliance Officer
As Chief Corporate Compliance Officer, Ms. Lyda leads global operations and is responsible for Contracts and Administration, Human Resources, Information Technology and Quality Assurance departments ensuring global alignment and operational excellence is achieved by applying high industry standards, policies, systems and processes across the organization. She provides strategy and direction to assure compliance with global GCP Regulations and Guidelines, and drives corporate initiatives for the harmonization of policies, procedures and training. Ms. Lyda has 40 years' experience in the oversight of preclinical and clinical research. She started her career at the FDA performing a variety of roles for 22 years in the enforcement of regulations and harmonization initiatives with international regulatory agencies to establish a framework for GCPs. She brings global experience having lived and worked in Switzerland for 10 years in the pharma industry. Ms. Lyda was a Consultant with PAREXEL International before joining Novartis Pharma Quality Assurance in Basel, in 2004. She returned to the US in 2008 and served 8 years at Worldwide Clinical Trials and was instrumental in harmonization of five companies before joining Linical Accelovance.
Harish Dave, MD, Global Oncology Therapeutic Lead
Dr. Dave is the Global Oncology Therapeutic Lead for Linical Accelovance Group. Dr. Dave has 25+ years of Phase I-IV clinical research experience including the conduct of over a 100 studies with a focus on hematology, oncology and transplantation as well as other areas of internal medicine. Dr. Dave provides integrated drug development and therapeutic advice, management of clinical trials, and expertise and due diligence for biotech, small, medium and large pharma and VC companies. He has scientific expertise in gene regulation, gene therapy and tumor immunology; clinical and academic expertise in hematology including coagulation disorders, oncology and transplantation; and industry experience in hematology/oncology drug development from pre-clinical to phase IV space and in biosimilars/biobetters and immunotherapeutics. Prior to joining Accelovance, Dr. Dave held positions at Quintiles, George Washington University Medical Center and VA Medical Center in Washington, DC and NIH in Bethesda, MD. Dr. Dave holds a MB, ChB from the University of Sheffield and a MBA from the TRIUM program (jointly awarded by NYU, London School of Economics and HEC).
Wendy Wang, MD, PhD, Managing Director Linical Accelovance China
Dr. Wendy (Wen-Ying) Wang is the Managing Director at Linical Accelovance China. As Head of Linical Accelovance China, Dr. Wang helps western pharmaceutical companies with global clinical trial registration, import drug registration, regulatory consultancy, clinical site management, and project management of multi-center global clinical trials in China. Dr. Wang has broad experiences in research, technical, sales, quality, medical and regulatory affairs within the biotechnology and pharmaceutical industries in the areas of bioactive enzymes, medicines, and vaccines in Greater China and Asia Pacific regions. Dr. Wang earned her clinical medicine degree from Shandong Weifang Medical College, Master's degree in gastroenterological physiology from Peking Union Medical College, and her PhD in the regulation of angiogenesis by vascular endothelial growth factor from the University of Bristol in the United Kingdom.
Cathy Gooch, Vice President, Talent & Resource Management
Cathy Gooch, MBA, is the Vice President of Talent and Resource Management. She is responsible for providing leadership in the areas of human resources, talent acquisition, talent management and utilization. Mrs. Gooch has 30 years’ experience as a human resources and recruitment professional and 18 years’ in the life sciences sector. Prior to joining Linical Accelovance, Mrs. Gooch was with Chiltern for ten years where she earned roles of progressively greater scope, complexity and responsibility in Human Resources, Resourcing Solutions and Global Talent Acquisition. She also worked with Worldwide Clinical Trials, and she began her career in clinical research while working with Kelly Services and Kelly Scientific. Mrs. Gooch holds a MBA in Human Resources Management from Columbia Southern University and a BA in Human Resources from Georgia State University.